valproic acid has been researched along with sodium benzoate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Aida, N; Iai, M; Kure, S; Osaka, H; Shimbo, H; Tsuji, M; Tsuyusaki, Y; Wada, T; Yamashita, S | 1 |
| Ching, CK; Fung, CW; Lam, CW; Luk, HM; Mak, CM; Poon, WL; Siu, TS; Tam, S; Tsang, JP; Wong, VC | 1 |
3 other study(ies) available for valproic acid and sodium benzoate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Paradoxical increase in seizure frequency with valproate in nonketotic hyperglycinemia.
Topics: Anticonvulsants; Brain; Child; Dextromethorphan; Excitatory Amino Acid Antagonists; Female; Humans; Hyperglycinemia, Nonketotic; Seizures; Sodium Benzoate; Valproic Acid | 2012 |
Arginase deficiency with new phenotype and a novel mutation: contemporary summary.
Topics: Anticonvulsants; Arginase; Base Sequence; Carcinoma, Hepatocellular; Cerebral Palsy; Codon, Nonsense; Combined Modality Therapy; Contraindications; Delayed Diagnosis; Dementia; Diagnostic Errors; Disease Progression; Epilepsy; Fatal Outcome; Female; Humans; Hyperargininemia; Liver; Liver Cirrhosis; Liver Neoplasms; Molecular Sequence Data; Palliative Care; Phenotype; Radiography; Sequence Deletion; Sodium Benzoate; Ultrasonography; Valproic Acid; Young Adult | 2012 |